Influence of schistosomiasis on host vaccine responses

JK Nono, SD Kamdem, F Musaigwa, CA Nnaji… - Trends in …, 2022 - cell.com
Schistosomiasis is a debilitating helminthiasis which commonly establishes as a chronic
infection in people from endemic areas. As a potent modulator of the host immune response …

Maternal Schistosomiasis: immunomodulatory effects with lasting impact on allergy and vaccine responses

M Lacorcia, CU Prazeres da Costa - Frontiers in Immunology, 2018 - frontiersin.org
Early exposure to immune stimuli, including maternal infection during the perinatal period, is
increasingly recognized to affect immune predisposition during later life. This includes …

[PDF][PDF] Placental and oral delivery of Schistosoma mansoni antigen from infected mothers to their newborns and children

AM Attallah, GE Ghanem, H Ismail… - American Journal of …, 2003 - academia.edu
A 63-kD Schistosoma mansoni antigen was detected in 149 (86%) of 174 umbilical cord
blood sera from infected women at delivery. Specific IgG antibodies to this antigen were also …

Infection by Schistosoma mansoni during pregnancy: effects on offspring immunity

VRF da Paz, D Sequeira, A Pyrrho - Life sciences, 2017 - Elsevier
About 25 million Brazilians live in areas at risk of contracting the disease caused by the
trematoda Schistosoma mansoni, the schistosomiasis mansoni. Although the adult parasites …

Maternal helminth infections and the shaping of offspring immunity

BG Dewals, LE Layland… - Parasite …, 2019 - Wiley Online Library
Helminth infections leave a long‐lasting immunological footprint on their hosts. Clinical
studies have provided first evidence that maternal helminth infections can result in an …

Schistosoma mekongi cathepsin B and its use in the development of an immunodiagnosis

M Sangfuang, Y Chusongsang, Y Limpanont… - Acta tropica, 2016 - Elsevier
Schistosomiasis mekongi is one of the most important human parasitic diseases caused by
Schistosoma mekongi in South-east Asia. The endemic area is the Mekong River sub-region …

Vaccination against Schistosoma mansoni infection using 74 kDa Schistosoma protein antigen

AM Attallah, H Attia, H Ismail, E Yones, EM El-Nashar… - Vaccine, 1999 - Elsevier
An IgG2a anti-Schistosoma mansoni mouse monoclonal antibody was shown to passively
protect Swiss mice. The 74 kDa target antigen was isolated from antigenic extracts of S …

[HTML][HTML] Impact of hepatitis C virus/Schistosoma mansoni coinfection on the circulating levels of HCV-NS4 protein and extracellular-matrix deposition in patients with …

AM Attallah, SO Abdallah, MS Albannan… - The American journal …, 2016 - ncbi.nlm.nih.gov
Abstract Hepatitis C virus (HCV)/Schistosoma mansoni coinfection is common in Egypt and
other developing countries. This study aimed to investigate the influence of HCV/S. mansoni …

Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study

AA Elhenawy, RH Ashour, N Nabih, NM Shalaby… - Biomedicine & …, 2017 - Elsevier
Background and objective Tyrphostin “AG1024” is an insulin growth factor-1 receptor (IGF-
1R) inhibitor that displayed an effect on the viability of larval and mature schistosomes in …

Utility of Slot‐Blot‐ELISA as a New, Fast, and Sensitive Immunoassay for Detection of Carcinoembryonic Antigen in the Urine Samples of Patients with Various …

S El‐Masry, IH El‐Sayed, M Lotfy… - … of Immunoassay and …, 2007 - Taylor & Francis
Carcinoembryonic antigen (CEA) is the most widely used clinical tumor marker. CEA
immunoassay has found acceptance as a diagnostic adjunct in clinical diagnosis of …